Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,678 | -14,032 | -10,812 | -4,666 | -25,513 |
| Depreciation Amortization | 924 | 923 | 923 | 548 | 2,320 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 246 |
| Accounts receivable | 58 | -20 | -47 | 71 | 581 |
| Accounts payable and accrued liabilities | -6,701 | -5,891 | -3,892 | -1,544 | -3,389 |
| Other Working Capital | -5,946 | -5,404 | -3,371 | -1,179 | -3,218 |
| Other Operating Activity | 17,024 | 11,865 | 8,854 | 2,601 | 6,022 |
| Operating Cash Flow | $-14,319 | $-12,559 | $-8,345 | $-4,169 | $-22,951 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,789 | -1,372 | 0 | N/A | 8,457 |
| PPE Investments | -69 | -69 | -69 | -36 | -319 |
| Investing Cash Flow | $-9,858 | $-1,441 | $-69 | $-36 | $8,138 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,556 |
| Common Stock Issued | 59,633 | 24,955 | 5,210 | 1,775 | 14,732 |
| Other Financing Activity | -143 | -143 | -143 | -140 | 7 |
| Financing Cash Flow | $59,490 | $24,812 | $5,067 | $1,635 | $13,183 |
| Exchange Rate Effect | 1,389 | 1,494 | 659 | 452 | -1,001 |
| Beginning Cash Position | 14,240 | 14,240 | 14,240 | 14,240 | 16,871 |
| End Cash Position | 50,942 | 26,546 | 11,552 | 12,122 | 14,240 |
| Net Cash Flow | $36,702 | $12,306 | $-2,688 | $-2,118 | $-2,631 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,319 | -12,559 | -8,345 | -4,169 | -22,951 |
| Capital Expenditure | -69 | -69 | -69 | -36 | -319 |
| Free Cash Flow | -14,388 | -12,628 | -8,414 | -4,205 | -23,270 |